AxoGen, Inc. operates as a regenerative medicine company. It focuses on advancing the science and commercialization of peripheral nerve repair solutions. It offers a range of surgical nerve reconstruction solutions, including Avance Nerve Graft, a processed nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa ExtraCellular Matrix (ECM) coaptation aid for tensionless repair of severed nerves; and AxoGuard Nerve Protector, a porcine submucosa ECM product used to wrap and protect injured peripheral nerves and reinforce coaptation sites while preventing soft tissue attachments. The company's products are used by surgeons during surgical interventions to repair traumatic nerve injuries. It procures and processes its tissue products in the United States and markets in the United States, Canada, Switzerland, Austria, and Italy. AxoGen, Inc. is headquartered in Alachua, Florida.